These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7821301)

  • 21. Extended Spectrum Beta-lactamases: Definition, Classification and Epidemiology.
    Ghafourian S; Sadeghifard N; Soheili S; Sekawi Z
    Curr Issues Mol Biol; 2015; 17():11-21. PubMed ID: 24821872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanisms of bacterial resistance to beta-lactams by beta-lactamases].
    Sawai T
    Nihon Rinsho; 1997 May; 55(5):1225-30. PubMed ID: 9155179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
    Philippon A; Jarlier V; Legrand P; Fournier G; Nicolas MH; Duval J
    Presse Med; 1989 Oct; 18(32):1560-6. PubMed ID: 2530532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enterobacteriaceae and beta-lactams : wild susceptibility patterns].
    Philippon A; Arlet G
    Pathol Biol (Paris); 2012 Apr; 60(2):112-26. PubMed ID: 22280847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal.
    Féria C; Ferreira E; Correia JD; Gonçalves J; Caniça M
    J Antimicrob Chemother; 2002 Jan; 49(1):77-85. PubMed ID: 11751770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Beta-lactamases and their role in resistance. PART 2: beta-lactamases in 21st century].
    Bedenić B
    Lijec Vjesn; 2005; 127(1-2):12-21. PubMed ID: 16145868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. in European septicaemia isolates.
    Pörnull KJ; Göransson E; Rytting AS; Dornbusch K
    J Antimicrob Chemother; 1993 Oct; 32(4):559-70. PubMed ID: 8288497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of Beta-lactamase resistance in enterobacteria].
    Koren J; Vaculíková A
    Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):103-7. PubMed ID: 17051471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
    Shi WF; Zhou J; Qin JP
    Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
    Pai H; Seo MR; Choi TY
    Antimicrob Agents Chemother; 2007 Jan; 51(1):366-8. PubMed ID: 17074790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of extended spectrum beta-lactamases.
    Philippon A; Ben Redjeb S; Fournier G; Ben Hassen A
    Infection; 1989; 17(5):347-54. PubMed ID: 2689354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA; Hare R; Papa E; Adam C; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolution of beta-lactamases.
    Bush K
    Ciba Found Symp; 1997; 207():152-63; discussion 163-6. PubMed ID: 9189640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative susceptibility of clinical isolates producing extended spectrum beta-lactamases to ceftibuten: effect of large inocula.
    Medeiros AA; Crellin J
    Pediatr Infect Dis J; 1997 Mar; 16(3 Suppl):S49-55. PubMed ID: 9076836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
    Shah AA; Hasan F; Ahmed S; Hameed A
    Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to gram-negative organisms due to high-level expression of plasmid-encoded ampC beta-lactamase blaCMY-4 promoted by insertion sequence ISEcp1.
    Nakano R; Okamoto R; Nagano N; Inoue M
    J Infect Chemother; 2007 Feb; 13(1):18-23. PubMed ID: 17334724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.
    Jarlier V; Nicolas MH; Fournier G; Philippon A
    Rev Infect Dis; 1988; 10(4):867-78. PubMed ID: 3263690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
    Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
    J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Plasmid resistance to 3d generation cephalosporins].
    Philippon A; Paul G; Vedel G; Nevot P
    Presse Med; 1988 Oct; 17(37):1883-9. PubMed ID: 2973578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.